Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

accounted for 18% of the total sample size in the Phase 2 study. A consistent top-enroller in acute schizophrenia clinical trials, Segal Trials contributed to the study sample size with a rate of ...

There is also a study to test the abuse potential of taking cebranopadol intranasally and a phase 3 trial in patients who have undergone toe surgery. The current plan for the rest of the year is ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Pheno Therapeutics to initiate a first-in-human Phase 1 clinical trial to test its oral candidate PTD802 in ...

The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a 7% rise from the previous year. Particularly, phase I trials saw an ...